We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alnylam Awarded $38.6M U.S. Government Contract to Develop RNAi Therapeutics for Biological Threats

News   Aug 10, 2007

 
Alnylam Awarded $38.6M U.S. Government Contract to Develop RNAi Therapeutics for Biological Threats
 
 
 

RELATED ARTICLES

World-first: Genetically Modified Miniature Human Livers Are Grown in the Laboratory

News

Researchers are the first to grow genetically modified miniature human livers in the laboratory, to emulate human liver disease progression and test therapeutics.

READ MORE

Predatory Journals Could Damage the Credibility of Scientific Publishing

News

'Predatory journals' pose a danger that could undermine the quality, integrity, and reliability of published scientific research, a new joint statement from three leading organizations, professional in medical writing and publication planning, has warned.

READ MORE

Unraveling the Genetic Secrets of the Glacier Ice Worm

News

Researchers uncover factors underlying the genetic structure of glacier ice worms.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE